Valérie Lavastre

KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2.

A. Mes-Masson, B. Brais, H. Van Esch, 2011, American journal of human genetics.

Activation of human neutrophils by the plant lectin Viscum album agglutinin‐I: modulation of de novo protein synthesis and evidence that caspases are involved in induction of apoptosis

V. Lavastre, M. Pelletier, K. Hostanska, 2000, Journal of leukocyte biology.

Discriminating polymorph distributions in pharmaceutical tablets using stimulated Raman scattering microscopy

H. Rigneault, Barbara Sarri, R. Canonge, 2019, Journal of Raman Spectroscopy.

Silver Nanoparticles Induce Degradation of the Endoplasmic Reticulum Stress Sensor Activating Transcription Factor-6 Leading to Activation of the NLRP-3 Inflammasome

J. Simard, F. Vallières, V. Lavastre, 2015, The Journal of Biological Chemistry.

Activation of human AML14.3D10 eosinophils by nanoparticles: Modulatory activity on apoptosis and cytokine production

J. Simard, F. Vallières, V. Lavastre, 2016, Journal of immunotoxicology.

Mechanisms Involved in Spontaneous and Viscum album Agglutinin-I-Induced Human Neutrophil Apoptosis: Viscum album Agglutinin-I Accelerates the Loss of Antiapoptotic Mcl-1 Expression and the Degradation of Cytoskeletal Paxillin and Vimentin Proteins Via Caspases

R. Saller, V. Lavastre, M. Pelletier, 2002, The Journal of Immunology.

TRIBUTYLTIN INDUCES HUMAN NEUTROPHIL APOPTOSIS AND SELECTIVE DEGRADATION OF CYTOSKELETAL PROTEINS BY CASPASES

V. Lavastre, D. Girard, Valérie Lavastre, 2002, Journal of toxicology and environmental health. Part A.

Viscum album agglutinin-I (VAA-I) induces apoptosis and degradation of cytoskeletal proteins in human leukemia PLB-985 and X-CGD cells via caspases: lamin B1 is a novel target of VAA-I.

V. Lavastre, D. Girard, S. Chiasson, 2005, Leukemia research.

Production of Reproducible Filament Batches for the Fabrication of 3D Printed Oral Forms

L. Delbreilh, V. Lavastre, J. Alié, 2021, Pharmaceutics.